Blinatumomab

(Mfr: AMG)(Conc: 0.375 mcg/mL^b)

Trimethoprim-sulfamethoxazole

(Mfr: RC)(Conc: 3.2 mg/mL^b,^c)

Remarks:

Persistent particulate formation when trimethoprim-sulfamethoxazole is added to blinatumomab; flakes transiently appeared when order of mixing was reversed

Ref:

³⁴⁰⁵,³⁴¹⁷